An infrared radiant panel is formed by overlaid substrates having conductors thereon which are electrically activated to generate heat to cause infrared radiation of desired wavelengths. The conductors are arranged to cancel magnetic fields caused by current flow therethrough. A conductive shield further suppresses fields generated by the panel.

Methods for treating ocular diseases such as dry age-related macular degeneration include administering non-invasive photobiomodulation light therapy in the context of a prior PBM treatment, on the basis of a subject response to prior PBM treatment, on the basis of a patient pre-treatment characteristic, and combinations thereof. In some embodiments, methods comprise administering PBM therapy to subjects who have received PBM about four to six months prior to the present administering. In some embodiments, methods comprise administering PBM therapy to subjects in early stages of dry age-related macular degeneration.

A far infrared film structure and a method of manufacturing the same are provided in this disclosure. The far infrared film structure includes a substrate, an oxide thin film, and an electrothermal film. The substrate has a metallic foil sheet and a plastic film overlappingly combined with each other. The oxide thin film is combined onto the metallic foil sheet and consists of an oxide gel formed by mixing an oxide powder and a sol. The electrothermal film is combined onto the plastic film, and the electrothermal film, the oxide thin film, and the substrate together constitute a flexible thin plate. Thus, the far infrared film structure is bendable to conform closely to the contours of a human body and also has a high content of the oxide powder. Therefore, the far infrared film structure is convenient to use and has a good far infrared emission rate.

An ultra-compact phototherapy apparatus for treating skin diseases includes: a PCB substrate in which a light emitting element and a pair of left and right first metal electrodes (positive pole) are formed on an upper surface and a second metal electrode is formed on a lower surface, a battery having a first electrode on an upper surface, which is in contact with the second metal electrode on the lower surface of the PCB substrate, and a second electrode on a lower surface, and an electrode body formed so that the battery is inserted inside and the PCB substrate is inserted in slidingly a front-rear direction, of which an upper inner side is selectively in contact with the first metal electrode of the PCB substrate.

A method of using nanoparticle (NP) spray to treat an infection in the respiratory system and far infrared radiation (FIR) to treat inflammation. The method uses a spray probe inserted into the airway of a patient to apply mSiO.sub.2 and FIR to a target site in the upper respiratory tract. FIR applied may be in the 3-10 μm range. The mSiO.sub.2 spray kills any organisms, including COVID-19 and FIR reduces inflammation resulting from infection. The treatment may be applied to intubated or spontaneously breathing patients and via the oral or nasal passages.

An apparatus for biophotonic tissue treatments comprising a wearable light emitter device, suitable to be configured to be applied to a body portion to be submitted to treatment. The light emitter device comprising a closed chamber, light guides being formed at the inside in order to transfer a preset-frequency light radiation at pre-fixed treatment points of the device. The light guides are connected to at least an optical fibre that direct thereof the light generated by at least a light radiation source arranged in a control unit for controlling the emission of light radiation. The control unit is operated by an operation unit for managing the treatment and for monitoring its implementation thereof according to set up parameters. The light guides being formed during the same production process and with the same material as the light emitter device.

Disclosed herein is a device for activating a mask pack, a photon therapy mask pack device, and a fiber based light emitting lighting device. The device for activating a mask pack includes: a first fiber fabric layer having a shape corresponding to that of a face of a wearer and having ductility for being closely adhered to the face of the wearer; a metal pattern layer attached to one surface of the first fiber fabric layer; an insulating resin adhesive layer attaching the first fiber fabric layer and the metal pattern layer to each other; a light emitting diode element attached onto the metal pattern layer and irradiating photon therapy light; an adhesive film layer covering the metal pattern layer and the light emitting diode element and in contact with the mask pack; and a power supplying module supplying power to the light emitting diode element to allow components of the mask pack to be better permeated into a skin of the wearer.

Disclosed is a thermal contact sensor for use in aesthetic skin by heat treatment for altering the aesthetic appearance of a subject. The thermal contact sensor measures the difference in sensor temperature when in contact or absence of contact with the skin and automatically operates a source of optical radiation to heat the skin.

The invention relates to a transcutaneous irradiation device which is essentially characterised in that it comprises: a top portion (1) suitable for positioning on the head (3) of a user and comprising at least one transcutaneous irradiation module (10) consisting of at least one irradiation source, and a bottom portion (9) suitable for being positioned on the abdomen (16) of the user and comprising at least one transcutaneous irradiation module (10) consisting of at least one irradiation source.

In particular, the transcutaneous irradiation device of the invention is configured for the prevention or treatment of neurological disorders and/or neurodegenerative diseases, preferably for the prevention or treatment of Alzheimer's disease, Parkinson's disease and/or Huntington's disease.

The present invention relates generally to therapeutic articles comprised of carbonaceous blend textile materials comprising yarns having about 25 to 100 weight % carbonaceous fiber and about 0 to 75 weight % fiber made of polyester, nylon, rayon, lyocell, cellulose, wool, silk, linen, bamboo, m-aramid, p-aramid, modacrylic, novoloid, melamine, regenerated cellulose, polyvinyl chloride, antistatic fiber, poly(p-phenylene benzobisoxazole) (PBO), polybenzimidazole (PBI), polysulphonamide (PSA), and combinations thereof, or other fibers not listed that are capable of being made into yarn and textile fabrics that are knit, woven, or nonwoven, and wherein the fabric has a weight from about 3 oz/yd.sup.2 to about 20 oz/yd.sup.2. Also encompassed within this invention is a method for using therapeutic textile articles having carbonaceous blend textile materials of the present disclosure for treatment of humans and animals with developmental neurological disorders, central nervous system disorders, autoimmune disorders, cardiovascular disease, sleep disorders, anxiety disorders, pain management, and diabetes.